انتشارات / RCMCI
تاریخ: 2018/03/18
توسط: Dr. Marjaneh Hejazi
منتشر شده در: Photodiagnosis and Photodynamic Therapy, 21, pp. 50-54
فایل های پیوست:
URL منتشر شده: https://www.ncbi.nlm.nih.gov/pubmed/29126958

 

Jamali, Z., Hejazi, S.M., Ebrahimi, S.M., Moradi-Sardareh, H., Paknejad, M.

Abstract:

Photodynamic therapy (PDT) has received high attention in cancer treatment due to its minimal side effects, specific cancer-targeting, non-invasion and low cost. It utilizes a specific group of anti-cancer drugs called photosensitizers (PS), which can be only activated under a certain wavelength light illumination and kills cancer cells. To screen the potential of PS and setup of PDT treatment protocol, it is essential to assess the PDT efficacy in vitro.